News stories about Keurig Dr Pepper (NYSE:KDP) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research group scores the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Keurig Dr Pepper earned a media sentiment score of 0.02 on Accern’s scale. Accern also gave press coverage about the company an impact score of 46.9278933981325 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

These are some of the news stories that may have impacted Accern Sentiment Analysis’s analysis:

Shares of NYSE:KDP opened at $23.35 on Tuesday. The company has a quick ratio of 0.75, a current ratio of 0.93 and a debt-to-equity ratio of 1.52. Keurig Dr Pepper has a 1 year low of $20.46 and a 1 year high of $126.65. The firm has a market cap of $4.27 billion, a P/E ratio of 5.14, a PEG ratio of 1.52 and a beta of 0.79.

Keurig Dr Pepper (NYSE:KDP) last announced its quarterly earnings data on Wednesday, August 8th. The company reported $1.30 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.29 by $1.01. The business had revenue of $1.89 billion during the quarter, compared to analyst estimates of $2.85 billion. Keurig Dr Pepper had a return on equity of 33.68% and a net margin of 16.10%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. analysts anticipate that Keurig Dr Pepper will post 1.04 earnings per share for the current year.

Several analysts recently issued reports on KDP shares. Bank of America set a $30.00 price objective on Keurig Dr Pepper and gave the stock a “buy” rating in a report on Monday, July 16th. Jefferies Financial Group cut their price objective on Keurig Dr Pepper from $25.00 to $22.00 and set a “hold” rating for the company in a report on Monday. Stifel Nicolaus started coverage on Keurig Dr Pepper in a report on Wednesday, July 11th. They set a “hold” rating and a $20.00 price objective for the company. Goldman Sachs Group started coverage on Keurig Dr Pepper in a report on Wednesday, July 18th. They set a “neutral” rating and a $26.00 price objective for the company. Finally, Citigroup increased their price objective on Keurig Dr Pepper from $15.46 to $26.00 and gave the stock a “neutral” rating in a report on Friday, August 10th. One analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $26.17.

In other Keurig Dr Pepper news, insider Maria A. Sceppaguercio-Gever bought 42,498 shares of the stock in a transaction on Wednesday, August 15th. The shares were purchased at an average cost of $23.53 per share, with a total value of $999,977.94. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Robert S. Singer bought 10,000 shares of the stock in a transaction on Friday, August 10th. The shares were acquired at an average cost of $23.75 per share, for a total transaction of $237,500.00. The disclosure for this purchase can be found here. Corporate insiders own 0.58% of the company’s stock.

Keurig Dr Pepper Company Profile

Keurig Dr Pepper Inc engages in the brewing system and specialty coffee businesses in the United States and Canada. The company sources, produces, and sells coffee, hot cocoa, teas, and other beverages in K-Cup, Vue, Rivo, K-Carafe, and K-Mug pods brands; coffee in traditional packaging, including bags and fractional packs; and other specialty beverages in pods.

See Also: Trading Strategy Methods and Types

Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.